Affiliated with a Castle Connolly Top Hospital
Who is Dr. Skinner, Urologist in Stanford, CA?
Dr. Eila Skinner, MD is an Urologist, who primarily practices in Stanford, CA with 2 additional practice locations. She is board certified by the American Board of Urology. Dr. Skinner graduated from Keck School of Medicine of the University of Southern California and completed her residency at USC/LAC Medical Center. Dr. Skinner is fluent in English and Spanish, and is currently seeing new patients. Dr. Skinner’s practice accepts Medicaid, Medicare, UnitedHealthcare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Skinner’s office at (312) 416-9997.
What are Areas of Expertise for Dr. Skinner?
Dr. Eila Skinner, MD is a highly-rated, board-certified Urologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Skinner empowers patients to confidently navigate their health journey, specializing in Bladder Cancer, Bladder Reconstruction, Continent Urinary Diversions, Urologic Cancer, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Skinner is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Skinner go to medical school and complete their residency?
Fellowship: USC Norris Comprehensive Cancer Center
Residency: USC/LAC Medical Center | USC/LAC-Keck School of Medicine
Medical School: Keck School of Medicine of the University of Southern California
Is Dr. Skinner board certified in Urologist?
Yes, Dr. Eila Skinner, MD is board certified by the American Board of Urology , American Board of Urology since 1992
What languages does Dr. Skinner speak?
Dr. Skinner and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Skinner treat?
As a Urologist, Dr. Skinner diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Skinner. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Bladder Cancer
- Urinary Bladder Cancer
- Bladder Carcinoma
- Bladder carcinoma
- Urothelial bladder cancer
ICD-10 Codes:
- C679: Malignant neoplasm of bladder, unspecified
- C672: Malignant neoplasm of lateral wall of bladder
- C674: Malignant neoplasm of posterior wall of bladder
- C670: Malignant neoplasm of trigone of bladder
- C673: Malignant neoplasm of anterior wall of bladder
- C675: Malignant neoplasm of bladder neck
Also known as:
- Personal History of Bladder Cancer
- Bladder Cancer
- Past bladder cancer
- Previous urinary bladder malignancy
- History of bladder tumor
ICD-10 Codes:
- Z8551: Personal history of malignant neoplasm of bladder
Also known as:
- Bladder Cancer
- Urinary Bladder Cancer
- Bladder Tumor
- Urothelial Carcinoma of Bladder
ICD-10 Codes:
- C678: Malignant neoplasm of overlapping sites of bladder
- C671: Malignant neoplasm of dome of bladder
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Cancer Follow-up Exam
- Cancer
- Post-cancer treatment checkup
- Malignancy surveillance
- Oncology follow-up
ICD-10 Codes:
- Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm
Also known as:
- Other General Symptoms
- Non-specific health complaints
- Various symptoms
- Unexplained health issues
ICD-10 Codes:
- R6889: Other general symptoms and signs
Also known as:
- Other Post-Surgery Condition
- Postoperative State
- Recovery After Surgery
- Surgical Follow-up
ICD-10 Codes:
- Z98890: Other specified postprocedural states
Also known as:
- Elevated PSA Level
- Prostate Cancer Screening
- Prostate Disease
- Prostate-Specific Antigen (PSA) Test
- Prostate Problems
- High Prostate Specific Antigen
- Abnormal PSA Test
- Increased PSA
ICD-10 Codes:
- R9720: Elevated prostate specific antigen [PSA]
Also known as:
- Other Kidney and Ureter Disorder
- Kidney Disease
- Ureteral Disorder
- Kidney and Ureter Problems
- Renal and Ureteral Disorders
ICD-10 Codes:
- N2889: Other specified disorders of kidney and ureter
Also known as:
- Visible Blood in Urine
- Urine and Urination
- Hematuria (Blood in the Urine)
- Gross hematuria
- Macroscopic hematuria
- Bloody pee
ICD-10 Codes:
- R310: Gross hematuria
Also known as:
- Cancer Surgery Aftercare
- After Surgery
- Cancer
- Post-cancer surgery care
- Oncology aftercare
- Cancer recovery follow-up
ICD-10 Codes:
- Z483: Aftercare following surgery for neoplasm
Also known as:
- Urinary Tract Infection
- UTI
- Bladder infection
- Kidney infection
- Urine infection
ICD-10 Codes:
- N390: Urinary tract infection, site not specified
Also known as:
- Enlarged Prostate
- Enlarged Prostate (BPH)
- Enlarged Prostate (Benign Prostatic Hyperplasia)
- Benign Prostatic Hyperplasia
- BPH
- Prostate Enlargement
ICD-10 Codes:
- N400: Benign prostatic hyperplasia without lower urinary tract symptoms
Also known as:
- Kidney Cancer
- Renal cancer
- Kidney carcinoma
- Renal cell carcinoma
ICD-10 Codes:
- C642: Malignant neoplasm of left kidney, except renal pelvis
Which procedures does Dr. Skinner perform as a Urologist?
As a Urologist, procedures performed by an Dr. Eila Skinner may include:
- Aesthetic Urology Consultation
- Bladder and Kidney Ultrasound
- Circumcision / Phimosis
- Cystoscopy
- Erectile Dysfunction (ED) Shockwave Therapy
- Erectile Dysfunction / Impotence / Male Sexual Dysfunction
- Evaluation of Kidney Mass
- Invasive Urologic Procedure
For detailed information, please contact Dr. Skinner's office.
Does Dr. Skinner accept my insurance?
Dr. Skinner accepts most major insurance plans. Important: Please call our office at (312) 416-9997 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Skinner accept in Stanford, CA?
Dr. Skinner in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
AllCare Health Plan
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
Santa Clara Family Health Plan
UnitedHealthcare
View All Insurances
Where is Dr. Skinner's office located?
Recognitions
Publications
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node
BJU INTERTIOL, 2014
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinbl
UROLOGIC ONCOLOGY-SEMIRS AND ORIGIL INVESTIGATIONS, 2013
Uriry Functiol Outcome Following Radical Cystoprostatectomy
JOURL OF UROLOGY, 2013
Combition of Molecular Alterations
CANCER, 2013
ICUD-EAU Intertiol Consultation on Bladder Cancer 2012: Uriry Diversion
EUROPEAN UROLOGY, 2013
Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
WORLD JOURL OF UROLOGY, 2012
Super Extended Versus Extended Pelvic Lymph Node Dissection
JOURL OF UROLOGY, 2011
Choosing the right uriry diversion: Patient's choice or surgeon's inclition?
UROLOGIC ONCOLOGY-SEMIRS AND ORIGIL INVESTIGATIONS, 2011
Disease-Free Survival at 2 or 3 Years Correlates With 5
JOURL OF UROLOGY, 2011
Early Complications of Cystectomy After High Dose Pelvic Radiation
JOURL OF UROLOGY, 2010
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy
JOURL OF UROLOGY, 2010
Intertiol validation of the prognostic value of lymphovascular invasion
BJU INTERTIOL, 2010
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T
WORLD JOURL OF UROLOGY, 2009
Guideline for the magement of nonmuscle invasive bladder cancer (Stages Ta, T1
JOURL OF UROLOGY, 2007
Radical cystectomy with extended lymphadenectomy
JOURL OF UROLOGY, 2007
Surgical benchmarks for the treatment of invasive bladder cancer
UROLOGIC ONCOLOGY-SEMIRS AND ORIGIL INVESTIGATIONS, 2007
Quality of life after cystectomy and uriry diversion: An evidence based alysis
JOURL OF UROLOGY, 2005
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical
JOURL OF UROLOGY, 2005
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy
JOURL OF UROLOGY, 2004
Prognosis of semil vesicle involvement by transitiol cell carcinoma of the bladder
JOURL OF UROLOGY, 2004
High-risk localized prostate cancer: primary surgery and adjuvant therapy
UROLOGIC ONCOLOGY-SEMIRS AND ORIGIL INVESTIGATIONS, 2003
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JOURL OF CLINICAL ONCOLOGY, 2001
Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit
JOURL OF UROLOGY, 1999
Hydronephrosis as a prognostic indicator in bladder cancer patients
JOURL OF UROLOGY, 1998
The effect of fisteride on the prostate gl
BRITISH JOURL OF CANCER, 1998
25-year experience in the magement of invasive bladder cancer by radical cystectomy
EUROPEAN UROLOGY, 1998
Orthotopic lower uriry tract reconstruction in women using the kock ileal neobladder
JOURL OF UROLOGY, 1997
Transitiol cell carcinoma involving the prostate with a proposed staging cl
JOURL OF UROLOGY, 1996
Magement of complex urologic injuries
SURGICAL CLINICS OF NORTH AMERICA, 1996
Complications of the afferent antireflux valve mechanism in the kock ileal reservoir
JOURL OF UROLOGY, 1996
Alterations in circulating levels of androgens and PSA during treatment with fisteride in men at
Stanczyk, F. Z., Skinner, E. C., Mertes, S., Spahn, M. F., Lobo, R. A., 1996
INDICATIONS FOR LOWER URIRY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER
JOURL OF UROLOGY, 1995
DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMOL BASIS
Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., Henderson, B., 1995
Uriry functiol outcomes in female neobladder patients.
World jourl of urology, 2014
Radical cystectomy and orthotopic uriry diversion in male patients with pT4a urothelial bladder
INTERTIOL JOURL OF UROLOGY, 2013
Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma
JOURL OF UROLOGY, 2013
Null Association Between Histology of First
AMERICAN JOURL OF EPIDEMIOLOGY, 2013
A novel precision-engineered microfiltration device for capture
EUROPEAN JOURL OF CANCER, 2013
Ultered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades
BJU INTERTIOL, 2013
Critical alysis and validation of lymph node density as prognostic variable in urothelial carcinoma
Urologic oncology, 2013
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder
BJU INTERTIOL, 2013
A precystectomy decision model to predict pathological upstaging
BJU INTERTIOL, 2013
Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy
JOURL OF UROLOGY, 2012
Multicenter validation of the prognostic value of patient age
WORLD JOURL OF UROLOGY, 2012
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy
BJU INTERTIOL, 2012
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
BJU INTERTIOL, 2011
Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy
JOURL OF UROLOGY, 2011
Discrepancy between clinical and pathological stage
BJU INTERTIOL, 2011
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes
UROLOGIA INTERTIOLIS, 2011
Stage pT0 at Radical Cystectomy Confers Improved Survival: An Intertiol Study of 4,430 Patients
JOURL OF UROLOGY, 2010
pT3 Substaging is a Prognostic Indicator
JOURL OF UROLOGY, 2010
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical
JOURL OF UROLOGY, 2010
The best treatment for high-grade T1 bladder cancer is cystectomy
UROLOGIC ONCOLOGY-SEMIRS AND ORIGIL INVESTIGATIONS, 2007
Functiol heterogeneity of prostatic intraepithelial neoplasia
BJU INTERTIOL, 2007
A critical alysis of perioperative mortality from radical cystectomy
JOURL OF UROLOGY, 2006
Pubovagil slings for stress uriry incontinence following radical cystectomy
JOURL OF UROLOGY, 2004
Prevention of prostate cancer with fisteride.
New England jourl of medicine, 2003
Quality of life with reconstruction.
Semirs in urologic oncology, 2001
Continent and orthotopic uriry diversion following radical cystectomy. Should these reconstructive
Surgical oncology clinics of North America, 1995
THE RATIOLE FOR EN-BLOC PELVIC LYMPH
JOURL OF UROLOGY, 1993
RADICAL CYSTECTOMY IN REGIOLLY ADVANCED BLADDER-CANCER
UROLOGIC CLINICS OF NORTH AMERICA, 1992
URIRY-DIVERSION
CURRENT PROBLEMS IN SURGERY, 1987
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node
BJU INTERNATIONAL, 2014
Long-term cancer control after radical prostatectomy
Urologic oncology, 2014
Impact of micropapillary urothelial carcinoma variant histology on survival after radical
Urologic oncology, 2014
Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder
Urologic oncology, 2014
Incidence and location of lymph node metastases in patients undergoing radical cystectomy for
Urologic oncology, 2014
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinbl
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013
Urinary Functional Outcome Following Radical Cystoprostatectomy
JOURNAL OF UROLOGY, 2013
Combination of Molecular Alterations
CANCER, 2013
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
EUROPEAN UROLOGY, 2013
Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
WORLD JOURNAL OF UROLOGY, 2012
Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System
EUROPEAN UROLOGY, 2012
Robotic and Laparoscopic High Extended Pelvic Lymph Node Dissection During Radical Cystectomy
EUROPEAN UROLOGY, 2012
Super Extended Versus Extended Pelvic Lymph Node Dissection
JOURNAL OF UROLOGY, 2011
Choosing the right urinary diversion: Patient's choice or surgeon's inclination?
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011
Disease-Free Survival at 2 or 3 Years Correlates With 5
JOURNAL OF UROLOGY, 2011
Lymph node dissection technique is more important than lymph node count
European Urology, 2011
Early Complications of Cystectomy After High Dose Pelvic Radiation
JOURNAL OF UROLOGY, 2010
Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy
JOURNAL OF UROLOGY, 2010
International validation of the prognostic value of lymphovascular invasion
BJU INTERNATIONAL, 2010
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T
WORLD JOURNAL OF UROLOGY, 2009
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1
JOURNAL OF UROLOGY, 2007
Radical cystectomy with extended lymphadenectomy
JOURNAL OF UROLOGY, 2007
Surgical benchmarks for the treatment of invasive bladder cancer
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007
Quality of life after cystectomy and urinary diversion: An evidence based analysis
JOURNAL OF UROLOGY, 2005
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical
JOURNAL OF UROLOGY, 2005
Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy
JOURNAL OF UROLOGY, 2004
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder
JOURNAL OF UROLOGY, 2004
High-risk localized prostate cancer: primary surgery and adjuvant therapy
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003
Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives
HEALTH PSYCHOLOGY, 2002
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JOURNAL OF CLINICAL ONCOLOGY, 2001
Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit
JOURNAL OF UROLOGY, 1999
Hydronephrosis as a prognostic indicator in bladder cancer patients
JOURNAL OF UROLOGY, 1998
The effect of finasteride on the prostate gl
BRITISH JOURNAL OF CANCER, 1998
Radical cystectomy for elderly patients with bladder carcinoma
CANCER, 1998
25-year experience in the management of invasive bladder cancer by radical cystectomy
EUROPEAN UROLOGY, 1998
Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who
UROLOGY, 1997
Orthotopic lower urinary tract reconstruction in women using the kock ileal neobladder
JOURNAL OF UROLOGY, 1997
Transitional cell carcinoma involving the prostate with a proposed staging cl
JOURNAL OF UROLOGY, 1996
Management of complex urologic injuries
SURGICAL CLINICS OF NORTH AMERICA, 1996
Complications of the afferent antireflux valve mechanism in the kock ileal reservoir
JOURNAL OF UROLOGY, 1996
Alterations in circulating levels of androgens and PSA during treatment with fin
Stanczyk, F. Z., Skinner, E. C., Mertes, S., Spahn, M. F., Lobo, R. A., 1996
INDICATIONS FOR LOWER URINARY-TRACT RECONSTRUCTION IN WOMEN AFTER CYSTECTOMY FOR BLADDER
JOURNAL OF UROLOGY, 1995
DOES THE RACIAL-ETHNIC VARIATION IN PROSTATE-CANCER RISK HAVE A HORMONAL BASIS
Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., Henderson, B., 1995
Female gender is associated with a worse survival after radical cystectomy
Urology, 2014
Urinary functional outcomes in female neobladder patients.
World journal of urology, 2014
Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder
INTERNATIONAL JOURNAL OF UROLOGY, 2013
Incidental Prostate Cancer in Patients with Bladder Urothelial Carcinoma
JOURNAL OF UROLOGY, 2013
Null Association Between Histology of First
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013
A novel precision-engineered microfiltration device for capture
EUROPEAN JOURNAL OF CANCER, 2013
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three
BJU INTERNATIONAL, 2013
Critical analysis and validation of lymph node density as prognostic variable in urothelial
Urologic oncology, 2013
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder
BJU INTERNATIONAL, 2013
A precystectomy decision model to predict pathological upstaging
BJU INTERNATIONAL, 2013
Reproductive Organ Involvement in Female Patients Undergoing Radical Cystectomy
JOURNAL OF UROLOGY, 2012
Multicenter validation of the prognostic value of patient age
WORLD JOURNAL OF UROLOGY, 2012
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy
BJU INTERNATIONAL, 2012
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
BJU INTERNATIONAL, 2011
Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk
CARCINOGENESIS, 2011
Prognostic Risk Stratification of Pathological Stage T3N0 Bladder Cancer After Radical Cystectomy
JOURNAL OF UROLOGY, 2011
Discrepancy between clinical and pathological stage
BJU INTERNATIONAL, 2011
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes
UROLOGIA INTERNATIONALIS, 2011
Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
JOURNAL OF UROLOGY, 2010
Extended lymphadenectomy in bladder cancer
CURRENT OPINION IN UROLOGY, 2010
pT3 Substaging is a Prognostic Indicator
JOURNAL OF UROLOGY, 2010
Validation of the AJCC TNM Substaging of pT2 Bladder Cancer
EUROPEAN UROLOGY, 2010
Characteristics and Outcomes of Patients With Clinical Carcinoma In Situ Only Treated With Radical
JOURNAL OF UROLOGY, 2010
Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with
EUROPEAN UROLOGY, 2010
The best treatment for high-grade T1 bladder cancer is cystectomy
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007
Functional heterogeneity of prostatic intraepithelial neoplasia
BJU INTERNATIONAL, 2007
A critical analysis of perioperative mortality from radical cystectomy
JOURNAL OF UROLOGY, 2006
Pubovaginal slings for stress urinary incontinence following radical cystectomy
JOURNAL OF UROLOGY, 2004
Prevention of prostate cancer with finasteride.
New England journal of medicine, 2003
Quality of life with reconstruction.
Seminars in urologic oncology, 2001
Continent and orthotopic urinary diversion following radical cystectomy. Should these
Surgical oncology clinics of North America, 1995
XANTHOGRANULOMATOUS PYELONEPHRITIS - CLINICAL FINDINGS AND SURGICAL CONSIDERATIONS
UROLOGY, 1994
THE RATIONALE FOR EN-BLOC PELVIC LYMPH
JOURNAL OF UROLOGY, 1993
RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER-CANCER
UROLOGIC CLINICS OF NORTH AMERICA, 1992
RADICAL CYSTECTOMY
AKTUELLE UROLOGIE, 1991
URINARY-DIVERSION
CURRENT PROBLEMS IN SURGERY, 1987
What is Dr. Skinner's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Skinner's National Provider Identifier (NPI) number is 1588673941.
What common questions do patients ask about Dr. Skinner?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Skinner
What is Dr. Eila Skinner's specialty?
Dr. Skinner is a Urologist near Stanford, CA. A urologist is a healthcare professional with specialization in managing both benign and malignant medical and surgical disorders of the genitourinary system and adrenal glands. They possess extensive knowledge and skills in endoscopic, percutaneous, and open surgical techniques for addressing congenital and acquired conditions of the urinary and reproductive systems, as well as their associated structures. Contact Dr. Skinner to book an appointment today.
Is this Dr. Eila Skinner affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Skinner is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Urologist?
Explore Urologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Eila Skinner accepting new patients in Stanford, CA?
Yes, Dr. Eila Skinner is accepting new patients at this time.
Does Dr. Eila Skinner offer online booking?
Please contact Dr. Skinner's office at (312) 416-9997 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Eila Skinner?
Please contact Dr. Skinner's office at (312) 416-9997 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Eila Skinner have?
Dr. Eila Skinner is certified by the American Board of Urology.
Other Urologist Near Stanford, CA
Urologist
Accepting patientsUrologist
Accepting patientsUrologist
Accepting patients